Recherche :
Recherche avancée
MICI
Cette rubrique ne peut être exhaustive et ne regroupe que des articles très récents ayant paru avoir un intérêt essentiellement clinique.
- Maladie de Crohn
- Budesonide and mesalazine in active Crohn's disease: a comparison of the effects on quality of life.
- Combined budesonide and antibiotic therapy for active Crohn's disease: a randomized controlled trial
- Long term outcome of patients with active Crohn's disease exhibiting extensive and deep ulcerations at colonoscopy
- Mortality and causes of death in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark.
- NOD2/CARD15 does not influence response to infliximab in Crohn's disease.
- Recurrence after abdominal surgery for Crohn's disease: relationship to disease site and surgical procedure
- Attitudes toward smoking and smoking behaviors of patients with Crohn's disease
- Long-term results of ileal pouch-anal anastomosis for colorectal Crohn's disease
- Management of Crohn's disease in adults
- Prospective, randomized trial comparing laparoscopic vs. conventional surgery for refractory ileocolic Crohn's disease
- Post-operative maintenance of Crohn’s disease remission with 6-mercaptopurine, mesalamine or placebo: A two-year trial.
- Capsule endoscopy in patients with suspected Crohn's disease and negative endoscopy.
- A randomized, double-blind, controlled withdrawal trial in Crohn’s disease patients in long-term remission on azathioprine.
- Ornidazole for prophylaxis of postoperative Crohn’s disease recurrence: A randomized, double-blind, placebo-controlled trial.
- Small bowel involvement in Crohn’s disease: a prospective comparison of wireless capsule endoscopy and computed tomography enteroclysis
- Endoscopic balloon dilation of ileal pouch strictures.
- Sargramostim for active Crohn’s disease.
- Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease
- Impact of the increasing use of immunosuppressants Crohn’s disease on the need for intestinal surgery.
- Progressive multifocal leukoencephalopathy after Natalizumab therapy for Crohn’s disease.
- Natalizumab induction and maintenance therapy for Crohn’s disease.
- Predictors of immunomodulator use as early therapy in pediatric Crohn's Disease.
- Risk factors for initial surgery in pediatric patients with Crohn’s disease.
- Infliximab Plus Azathioprine for Steroid-Dependent Crohn’s Disease Patients : A randomized Placebo-Controlled Trial.
- A meta-analysis of the yeld of capsule endoscopy compared to other diagnostic modalities in patients with non-structuring small bowel Crohn’s Disease.
- A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's
- A preliminary study of growth hormone therapy for Crohn's disease
- Alendronate increases lumbar spine bone mineral density in patients with Crohn's disease
- Bowel wall thickness measured by ultrasound as a marker of Crohn's disease activity in children
- Fracture risk is increased in Crohn's disease, but not in ulcerative colitis
- Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI
- Risk factors for surgery and postoperative recurrence in Crohn's disease
- An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's disease
- Clinical course and costs of care for Crohn's disease: Markov model analysis of a population-based cohort
- Crohn's disease severity in familial and sporadic cases
- Treatment of Crohn's disease at the turn of the century
- Screening and surveillance colonoscopy in chronic Crohn's colitis
- Smoking cessation and the course of Crohn's disease: an intervention study
- Infliximab for the treatment of fistulas in patients with Crohn's disease
- Switch from systemic steroids to budesonide in steroid dependent patients with inactive Crohn's disease
- Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent
- Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease
- Endoscopic mucosal biopsies are useful in distinguishing granulomatous colitis due to Crohn's disease from tuberculosis
- Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial
- Tumour necrosis factor alpha and interleukin 1beta in relapse of Crohn's disease
- A comparison of budesonide and mesalamine for active Crohn's disease. International Budesonide-Mesalamine Study Group
- Mesalamine in the treatment of mild to moderate active Crohn's ileitis: results of a randomized, multicenter trial
- Maladie de Crohn jéjuno-iléale diffuse : une forme séparée de la maladie ?
- Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn’s disease
- Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. North American Azathioprine Study Group
- Oral contraceptive use and the clinical course of Crohn's disease: a prospective cohort study
- Rectum exclus au cours de la maladie de Crohn : quel est le risque de dysplasie ?
- Thalidomide therapy for patients with refractory Crohn's disease: an open-label trial
- Transabdominal bowel sonography for the detection of intestinal complications in Crohn's disease
- Oral budesonide for prevention of postsurgical recurrence in Crohn's disease. The IOIBD Budesonide Study Group
- Randomised trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn's disease
- Side effects of azathioprine in patients with Crohn's disease.
- Remission in patients with Crohn's disease is associated with improvement in employment and quality of life and a decrease in hospitalizations and surgeries.
- Virtual colonoscopy compared with conventional colonoscopy for stricturing postoperative recurrence in Crohn's disease.
- Capsule endoscopy vs. push enteroscopy and enteroclysis in suspected small-bowel Crohn's disease.
- Trichuris suis therapy in Crohn’s disease.
- Human Anti- Tumor Necrosis Factor Monoclonal Antibody (Adalimumab) in Crohn’s Disease : the Classic-1 trial.
- Clinical evolution of luminal and perianal Crohn’s disease after inducing remission with infliximab: how long should patients be treated?
- Predictor for disabling Crohn's disease.
- Utility of serological markers in predicting the early occurrence of complications and surgery in pediatric Crohn’s Disease patients.
- Human anti-tumor necrosis factor monoclonal antibody (Adalimumab) in Crohn’s disease: the ClASSIC-I trial
- Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease.
- Rectocolite hémorragique
- Cigarette smoking and appendectomy are risk factors for extraintestinal manifestations in ulcerative colitis
- Endoscopic and histologic evaluation together with symptom assessment are required to diagnose pouchitis.
- Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial.
- Long-term treatment of ulcerative colitis with ciprofloxacin: a prospective, double-blind, placebo-controlled study.
- Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study.
- Infliximab for refractory ulcerative colitis.
- Hodgkin's disease risk is increased in patients with ulcerative colitis.
- Restorative proctocolectomy for distal ulcerative colitis.
- Budesonide enema for the treatment of active, distal ulcerative colitis and proctitis: a dose-ranging study. U.S. Budesonide enema study group.
- Ulcerative colitis: female fecundity before diagnosis, during disease, and after surgery compared with a population sample.
- Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis.
- An open-labeled, randomized study comparing systemic interferon-alpha-2A and prednisolone enemas in the treatment of left-sided ulcerative colitis.
- Appendectomy and protection against ulcerative colitis.
- Trichuris suis therapy for active ulcerative colitis: A randomized controlled trial.
- Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo co
- Infliximab for induction and maintenance therapy for Ulcerative Colitis.
- Risk factors for diseases of ileal pouch-anal anastomosis after restorative proctocolectomy for ulcerative colitis.
- Appendectomy protects against the development of ulcerative colitis and reduces its recurrence: results of a multicenter case-controlled study in Japan.
- Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps.
- Increased risk of cancer in ulcerative colitis: a population-based cohort study.
- Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis.
- Female infertility after ileal pouch-anal anastomosis for ulcerative colitis.
- Systematic review: short-term adverse effects of 5-aminosalicylic acid agents in the treatment of ulcerative colitis.
- Fluorescence endoscopy for the detection of low and high grade dysplasia in ulcerative colitis using systemic or local 5-aminolaevulinic acid sensitisation.
- Indigo carmine-assisted high-magnification chromoscopic colonoscopy for the detection and characterisation of intraepithelial néoplasia in ulcerative colitis: a prospective evaluation.
- Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis.
- Maternal and Fetal Outcome After Colectomy for Fulminant Ulcerative Colitis During Pregnancy: Case Series and Literature Review.
- Safety of Celecoxib in patients with ulcerative colitis in remission: a randomized, placebo-controlled, pilot study.
- Sporadic adenoma in ulcerative colitis: endoscopic resection is an adequate treatment.
- A randomised, dose-finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis.
- Predictive and protective factors associated with colorectal cancer in ulcerative colitis: a case-control study.
- Colectomy with ileorectal anastomosis preserves female fertility in ulcerative colitis.
- Thirty Year Analysis of a Colonoscopic Surveillance Programme for Neoplasia in Ulcerative Colitis.
- MICI en général
- Rofecoxib and ealy relapse of inflammatory bowel disease : an open-label trial.
- An open-label trial of the selective cyclo-oxygenase-inhibitor, rofecoxib, in inflammatory bowel disease-associated periperical arthritis and arthralgias.
- Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease.
- Aminosalicylates and Colorectal Cancer in IBD: A Not-So Bitter Pill to Swallow
- 5-aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study
- The role of breastfeeding in postpartum disease activity in women with inflammatory bowel disease.
- Antibiotic use and the risk of flare of inflammatory bowel disease.
- Risk factors for inflammatory bowel disease in the general population.
- Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine.
- Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: A randomized, placebo-controlled study.
- Intravenous Iron Sucrose versus Oral Iron Supplementation for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease—A Randomized, Controlled, Open-Label, Multicenter Stud
- Efficacy and tolerability of oral iron therapy in inflammatory bowel disease: a prospective, comparative trial.
- Incidence, risk factors and clinical course of thiopurine-induced liver injury in patients with inflammatory bowel disease.
- Colorectal Cancer Prognosis Among Patients With Inflammatory Bowel Disease
- Live events and inflammatory bowel disease relapse: a prospective study of patients enrolled in remission.
- Capsule involvement versus enteroclys in the detection of small-bowel involvement in Crohn’s disease: A prospective trial.
- Geographical Variations of Inflammatory Bowel Disease in France: A Study Based on National Health Insurance Data.
- Infliximab for the treatment of pyoderma gangrenosum: a randomised, double-blind placebo-controlled trial.
- Review article: helminths as therapeutic agents for inflammatory bowel disease.
- Mesalamine-Related Lung Disease: Clinical, Radiographic, and Pathologic Manifestations.
- Appendectomy and subsequent risk of inflammatory bowel diseases.
- The SIBDQ: further validation in ulcerative colitis patients
- The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review
- Cancer risk in patients with inflammatory bowel disease: a population-based study
- Inflammatory bowel disease is not associated with an increased risk of lymphoma
- Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide
- Therapy of inflammatory bowel disease
- Smoking and inflammatory bowel disease
- Measurement of thiopurine methyltransferase activity and azathioprine metabolites in patients with inflammatory bowel disease
- The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study
- Utilisation of erythrocyte 6-thioguanine metabolite levels to optimise azathioprine therapy in patients with inflammatory bowel disease
- The role of aminosalicylates at the beginning of the new millennium in the treatment of chronic inflammatory bowel disease
- Pancréatites aiguës induites par les médicaments dérivé de l'acide 5-aminosalicylic : rapport de cas et examen de la littérature
- Bone mineral density in patients with recently diagnosed inflammatory bowel disease
- Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease
- Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease. British Society of Gastroenterology
- Birth outcome in women exposed to 5-aminosalicylic acid during pregnancy: a Danish cohort study.
- Stem cell transplantation for inflammatory bowel disease: practical and ethical issues
- Coût de la première prise en charge des maladies inflammatoires chroniques intestinales
- HLA-DR and -DQ phenotypes in inflammatory bowel disease: a meta-analysis
- Pronostic de la grossesse au cours des maladies inflammatoires chroniques intestinales
- CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease
- Epidemiology of inflammatory bowel diseases in the elderly in the province of Liege
- Inflammatory bowel disease
- Laparoscopic surgery for inflammatory bowel disease: results of the past decade
- Azathioprine: an update on clinical efficacy and safety in inflammatory bowel disease
- Inflammatory bowel disease
- Valeur diagnostique de l'échographie de haute fréquence dans la maladie de Crohn et cancers coliques
- Why children with inflammatory bowel disease are diagnosed at a younger age than their affected parent
- Appendicectomy, childhood hygiene, Helicobacter pylori status, and risk of inflammatory bowel disease: a case control study
- Maladies inflammatoires chroniques intestinales et grossesse. Etude de cas
- Inflammatory Bowel Disease
- Rectal endosonography in inflammatory bowel disease: differential diagnosis and prediction of remission
- Risk of acute pancreatitis in patients with chronic inflammatory bowel disease. A Danish 16-year nationwide follow-up study
- The intestinal mucus layer from patients with inflammatory bowel disease harbors high numbers of bacteria compared with controls
- Transrectal ultrasound in the diagnosis and management of inflammatory bowel disease
- Biologics in inflammatory bowel disease: how much progress have we made ?
- Clinical significance of azathioprine active metabolite concentrations in inflammatory bowel disease.